Description

Lazolvan Syrup 15 mg/5 ml. 100 ml

Ingredients

Active ingredient: Each 5 ml of Lazolvan syrup contains 15 mg of Ambroxol Hydrochloride. Other inactive ingredients include sucrose, glycerol, hydroxyethylcellulose, sodium benzoate, citric acid monohydrate, and purified water.

Dosage

Recommended dosage: Adults and children over 12 years: 10 ml (30 mg) 3 times daily. Children 6-12 years: 5 ml (15 mg) 2-3 times daily. Children 2-6 years: 2.5 ml (7.5 mg) 3 times daily. It is important to follow the dosage instructions provided by your healthcare provider.

Indications

Lazolvan syrup is indicated for the treatment of respiratory conditions associated with viscid mucus, such as acute and chronic bronchitis, bronchial asthma, bronchiectasis, and pneumonia. It helps to loosen and clear mucus in the airways, making it easier to breathe.

Contraindications

Do not use Lazolvan syrup if you are allergic to Ambroxol Hydrochloride or any other ingredients in the product. It is not recommended for use in children under 2 years of age without medical advice.

Directions

Shake the bottle well before use. Measure the prescribed dose using the provided measuring cup. The syrup can be taken with or without food. Do not exceed the recommended dosage unless directed by a healthcare professional.

Scientific Evidence

Ambroxol, the active ingredient in Lazolvan syrup, has been extensively studied for its mucolytic and expectorant properties. Research has shown that Ambroxol helps to increase the production of respiratory tract fluid, reduce mucus viscosity, and improve mucociliary clearance, leading to easier expectoration of mucus.

Additional Information

Storage: Store Lazolvan syrup at room temperature away from moisture and heat. Keep it out of reach of children. Side effects: Common side effects may include gastrointestinal disturbances, such as nausea and diarrhea. If you experience any severe side effects, seek medical attention immediately.

Pharmacologically, Lazolvan syrup works by stimulating the production of surfactant in the lungs, which helps to reduce the adhesion of mucus to the bronchial walls. This action makes it easier for the cilia in the respiratory tract to move the mucus out of the airways, improving breathing and reducing cough.

Clinical trials have demonstrated the efficacy of Ambroxol in improving symptoms of respiratory conditions characterized by excessive mucus production. A study published in the Journal of Pulmonary Medicine showed that Ambroxol significantly reduced cough frequency and severity in patients with chronic bronchitis compared to a placebo group.